Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
1.0 |
High Similarity |
NPD5124 |
Phase 1 |
0.8462 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8309 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8162 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7914 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7881 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7879 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7868 |
Intermediate Similarity |
NPD3225 |
Approved |
0.781 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7808 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7682 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7664 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7662 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7613 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7582 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7535 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7466 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7436 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7424 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7417 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7254 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7231 |
Intermediate Similarity |
NPD3134 |
Approved |
0.723 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.723 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7203 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD920 |
Approved |
0.7154 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7124 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7114 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7067 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7055 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7045 |
Intermediate Similarity |
NPD290 |
Approved |
0.7045 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7044 |
Intermediate Similarity |
NPD37 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7034 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7019 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7019 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7012 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7007 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7007 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7 |
Intermediate Similarity |
NPD1778 |
Approved |
0.6994 |
Remote Similarity |
NPD5494 |
Approved |
0.6993 |
Remote Similarity |
NPD7466 |
Approved |
0.6993 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6273 |
Approved |
0.6987 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD1607 |
Approved |
0.6978 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6964 |
Remote Similarity |
NPD7472 |
Approved |
0.6964 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD4288 |
Approved |
0.6957 |
Remote Similarity |
NPD2415 |
Discontinued |
0.6951 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD1203 |
Approved |
0.6941 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD846 |
Approved |
0.6923 |
Remote Similarity |
NPD940 |
Approved |
0.6909 |
Remote Similarity |
NPD5710 |
Approved |
0.6909 |
Remote Similarity |
NPD5711 |
Approved |
0.6908 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6897 |
Remote Similarity |
NPD3691 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD3690 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD2801 |
Approved |
0.6887 |
Remote Similarity |
NPD5588 |
Approved |
0.6887 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6884 |
Remote Similarity |
NPD7157 |
Approved |
0.6883 |
Remote Similarity |
NPD7003 |
Approved |
0.6882 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6871 |
Remote Similarity |
NPD7095 |
Approved |
0.6859 |
Remote Similarity |
NPD1511 |
Approved |
0.6859 |
Remote Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD1608 |
Approved |
0.6848 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6846 |
Remote Similarity |
NPD2203 |
Discontinued |
0.6845 |
Remote Similarity |
NPD7228 |
Approved |
0.6845 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD4477 |
Approved |
0.6842 |
Remote Similarity |
NPD4476 |
Approved |
0.6842 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD7340 |
Approved |
0.6832 |
Remote Similarity |
NPD4433 |
Discontinued |
0.6831 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6829 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6829 |
Remote Similarity |
NPD919 |
Approved |
0.6828 |
Remote Similarity |
NPD6362 |
Approved |
0.6824 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6824 |
Remote Similarity |
NPD1048 |
Approved |
0.6821 |
Remote Similarity |
NPD2200 |
Suspended |
0.6813 |
Remote Similarity |
NPD6502 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6806 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6805
|
Remote Similarity |
NPD7286 |
Phase 2 |